Development and Validation of an Integrated Metabolism‐Obesity Index for Screening Renal Impairment in Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Key Points

• The research aims to develop and validate a metabolism-obesity index for assessing renal impairment in type 2 diabetes patients.
• Developed the Integrated Metabolism‐Obesity Index (InMOI)
• Conducted validation across a relevant population
• Analyzed the role of visceral obesity in diabetic kidney disease
• The InMOI was effective in identifying early signs of renal impairment
• Visceral obesity significantly correlated with diabetic kidney disease
• The tool is practical for large-scale screening efforts